Sign In
Buy BHVN
$10.81
+0.680 (+6.71%)
At Close: Jun 03, 2026
What Caused Biohaven (BHVN) Shares To Drop More Than 16% After Hours?
01:52am, Thursday, 25'th Dec 2025
Biohaven shares fell 16.19% in after-hours trading Wednesday after its Phase 2 depression drug trial missed the primary endpoint.
Biohaven's depression drug fails mid-stage trial, shares fall
03:24pm, Wednesday, 24'th Dec 2025
Biohaven said on Wednesday its experimental depression drug did not meet the main goal of a mid-stage trial, adding to a string of trial and regulatory setbacks for the drugmaker this year.
Biohaven Provides Update From Phase 2 Proof-of-Concept Study with BHV-7000 in Major Depressive Disorder
01:00pm, Wednesday, 24'th Dec 2025
NEW HAVEN, Conn., Dec. 24, 2025 /PRNewswire/ -- Biohaven Ltd.
Wall Street Analysts Predict an 88.57% Upside in Biohaven Ltd. (BHVN): Here's What You Should Know
10:57am, Wednesday, 24'th Dec 2025
The consensus price target hints at an 88.6% upside potential for Biohaven Ltd. (BHVN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings es
Biohaven Ltd. (BHVN) Upgraded to Buy: Here's What You Should Know
01:01pm, Friday, 19'th Dec 2025
Biohaven Ltd. (BHVN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
In a pretreated population of participants with advanced/metastatic cancer and the majority with prior PD-(L)1 treatment, BHV-1510 2.5 mg/kg Q3W plus cemiplimab resulted in confirmed objective respon
How Much Upside is Left in Biohaven Ltd. (BHVN)? Wall Street Analysts Think 127.52%
10:56am, Thursday, 04'th Dec 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 127.5% in Biohaven Ltd. (BHVN). While the effectiveness of this highly sought-after metric is questionable, the
Pre-Market Stock Futures: The futures are trading higher on Wednesday after a stellar day across Wall Street on Tuesday. All of the major indices finished the day higher, with the technology-heavy NAS
AXQ Capital LP Boosts Stake in Biohaven Ltd. $BHVN
03:36am, Tuesday, 25'th Nov 2025
AXQ Capital LP grew its stake in shares of Biohaven Ltd. (NYSE: BHVN) by 59.8% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,
Biohaven Insiders Bet $33 Million on a Turnaround
12:37pm, Thursday, 20'th Nov 2025
When corporate executives make multi-million-dollar personal investments in the company they lead, it is one of the most potent signals an investor can receive. At Biohaven NYSE: BHVN, that signal ha
Biohaven's Chief Accounting Officer Scooped Up 17,000 Shares. Is the Stock a Buy?
05:15pm, Wednesday, 19'th Nov 2025
On November 17, 2025, Biohaven's Chief Accounting Officer, George Clark, acquired 17,000 shares of company stock. Mr. Clark's purchase was valued at approximately $144,800.
NEW HAVEN, Conn. , Nov. 13, 2025 /PRNewswire/ -- Biohaven Ltd.
Biohaven Q3 Earnings: Falling Back To Earth With A Thud
03:54pm, Wednesday, 12'th Nov 2025
Biohaven (BHVN) narrows focus to three late-stage clinical programs and implements cost-cutting to address heavy R&D spending and steep share price declines. BHVN's pipeline includes Opakalim for depr
FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
08:10am, Wednesday, 12'th Nov 2025
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Wednesday.
Biohaven Announces Pricing of $175 Million Public Offering of Common Shares
07:15am, Wednesday, 12'th Nov 2025
NEW HAVEN, Conn. , Nov. 12, 2025 /PRNewswire/ -- Biohaven Ltd.
